OTCM
EDXC
Market cap2mUSD
Jun 12, Last price
0.00USD
1D
4.17%
1Q
-50.00%
Jan 2017
-90.43%
IPO
-43.75%
Name
Endexx Corp
Chart & Performance
P/E
—
P/S
0.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
11.79%
Rev. gr., 5y
37.42%
Revenues
4m
+205.92%
Net income
-6m
L+32.73%
CFO
-2m
L+10.95%
Profile
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
| Income | |||||||||
Revenues | 3,908 205.92% | 1,278 96.40% | |||||||
Cost of revenue | 5,062 | 4,619 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,154) | (3,342) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (1,976) | 767 | |||||||
Tax Rate | |||||||||
NOPAT | 822 | (4,108) | |||||||
Net income | (6,498) 32.73% | (4,896) -36.90% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 12,434 | 6,571 | |||||||
Long-term debt | 2,977 | 3,401 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 15,404 | 7,607 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (1,623) | (1,463) | |||||||
CAPEX | (3) | ||||||||
Cash from investing activities | (1,490) | ||||||||
Cash from financing activities | 974 | 3,298 | |||||||
FCF | 13,291 | (5,735) | |||||||
| Balance | |||||||||
Cash | 8 | 365 | |||||||
Long term investments | 2,000 | ||||||||
Excess cash | 2,302 | ||||||||
Stockholders' equity | (53,132) | (43,852) | |||||||
Invested Capital | 48,752 | 44,847 | |||||||
ROIC | 1.76% | ||||||||
ROCE | 26.35% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 504,709 | 503,984 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (1,144) | (3,321) | |||||||
EV/EBITDA | |||||||||
Interest | 3,796 | 1,241 | |||||||
Interest/NOPBT | |||||||||